PROGRAM
Wednesday 6 July 2022
Location: Education Room 3 (Education Center Erasmus MC)
| EDEN pre-conference course ‘Trials and alternative designs’ (physical attendance only) | |||
| 14:00-17:30 | Chairs: Dr. Chen Hu, Drs. Celeste Eggermont | ||
| 14.00-15.00 | Dr. Marlies de Graaf | BioDay Registry | |
| 15.00-15.30 | Dr. Tessa Niemeyer | Innovative phase I/IIa trials in dermatology | |
| 15:30-16:00 | |||
| 16.00-17.00 | Prof. Dr. Lex Burdorf | Alternatives to the randomized controlled trial | |
| 17.00-17.30 | Dr. Renske Schappin | What is a pragmatic clinical trial? | |
Thursday 7 July 2022
Location: Queridozaal (Education Center Erasmus MC)
| 8:00-8:30 | Registration and welcome with coffee/tea | |
| 8.30-9.00 | Opening Ceremony | Vincent Karremans (Vice Mayor of Rotterdam) |
| 9.00-10.30 | Session 1: Atopic Dermatitis Chairs: Prof.dr. Carsten Flohr / Prof.dr. Tamar Nijsten | |
| 9.00-9.30 | Dr. Katrina Abuabara | Epidemiological studies of Atopic Dermatitis |
| 9.30-10.00 | Dr. Roxanne Gal | Trials within Cohorts (TwiCs) design |
| 10.00-10.15 | Marjolein Brands | Exposure, Work-related Factors, Absenteeism and Presenteeism in Subjects With Hand Eczema: Data from the Dutch General Population |
| 10.15-10.30 | Prof.dr. Robert Dellavalle | Real world prescribing patterns of dupilumab for atopic dermatitis |
| 10.30-11.00 | Coffee Break | |
| 11.00-12.30 | Session 2: Data-analyses Chairs: Dr. Loes Hollestein/ Dr. Michael Ming | |
| 11.00-11.30 | Prof. Dr. Hester Lingsma | Clinical Prediction Models |
| 11.30-12.00 | Dr. Yunlei Li | Integrating multi-level omics data |
| 12.00-12.15 | Barbara Rentroia-Pacheco | Development of a clinico-pathological model to estimate the absolute metastatic risk in patients with cutaneous squamous cell carcinoma |
| 12.15-12.22 | Tobias Sangers | Artificial Intelligence (AI) based skin cancer prediction using 2D facial images: a proof-of-concept study |
| 12.22-12.29 | Dr. Eunyoung Cho | Photosensitizing antihypertensive medication and risk of skin cancer among postmenopausal women |
| 12.30-13.30 | Lunch | |
| 13.30-15.00 | Session 3: Epidemiological study designs Chairs: Dr. Junko Takeshita / Prof.dr. Alexander Nast | |
| 13.30-14:00 | Dr. Junko Takeshita | Racial-ethnic disparities in Atopic Dermatitis |
| 14:00-14:15 | Celeste Eggermont | Development and Validation of an Algorithm to Identify Patients with Advanced Cutaneous Squamous Cell Carcinoma from Pathology Reports |
| 14.15-14.30 | Zachary Hopkins | Outcome comparison methodology in dermatologic clinical trials: Tradition impeding progress |
| 14.30-14.37 | Sam Cook | A national cancer registry cohort study of sebaceous carcinoma incidence, associated malignancies and Lynch syndrome/Muir-Torre screening in England 2008-2018 |
| 14.37-14.44 | Dr. Aaron Secrest | Benefits and value of the routine collection and clinical use of patient-reported outcomes in dermatology |
| 14.44-14.53 | Anna Andersson | Epidemiology of pediatric atopic dermatitis in a cohort of children in Greenland |
| 15.00-15.30 | Coffee Break | |
| 15.30-16.45 | Session 4: Systematic reviews and meta-analyses Chairs: Dr. Aaron Drucker / Dr. Emilie Sbidian | |
| 15.30-16.00 | Dr. Emilie Sbidian | Why do a network meta-analysis and key methodological points |
| 16.00-16.30 | Dr. Bram Rochwerg | Assessing certainty of evidence of NMA and incorporating NMA into guidelines |
| 16.30-16.45 | Robin Guelimi | Overlapping network meta-analyses on psoriasis systemic treatments, an overview: quantity does not make quality |
| 18:00 | Dinner at Louise petit restaurant, location: veerhaven 12-13b (15-20 minute walk from Erasmus MC) | |
Friday 8 July 2022
Location: Queridozaal (Education Center Erasmus MC)
| 9.00-10.30 | Session 5: Skin Cancer Chairs: Dr. Marlies Wakkee / Dr. Eunyoung Cho | |
| 9.00-9.30 | Dr. Adewole Adamson | The Melanoma Epidemic |
| 9.30-10.00 | Prof.dr. David Whiteman | The Qskin study |
| 10.00-10.15 | Yuan Ni | Risk of developing a second primary melanoma following diagnosis of a first primary melanoma: A population-based Australian cohort |
| 10.15-10.30 | Anna Smak Gregoor | Artificial Intelligence in Mobile Health for skin cancer diaGnostics at Home (AIM HIGH): A pilot feasibility study |
| 10.30-11.00 | Coffee Break | |
| 11.00-13.00 | Session 6: Routinely collected health care data Chairs: Prof.dr. Tamar Nijsten/ dr. Ignacio Garcia Doval | |
| 11.00-11.30 | Prof.dr. Ron Herings | The pro's and con's of pharmacoepidemiological research |
| 11.30-11.45 | Dr. Michael Ming | Factors associated with adherence to skin self-examination recommendations for melanoma patients |
| 11.45-12.00 | Dr. Florence Poizeau | The concomitant use of proton pump inhibitors and BRAF inhibitors in metastatic melanoma |
| 12.00-12.15 | Dr. Léa Hoisnard | Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study |
| 12.15-12.22 | Dr. Clio Dessinioti | A retrospective study of the association of melanoma diameter with Breslow thickness. |
| 12.22-12.29 | Dr. Lucy Navsaria | Body locations of keratinocyte carcinomas in the US Medicare population: a cohort study |
| 12.30-13.00 | Prof.dr. Arfan Ikram | Principles of confounder selection |
| 13.00-- | Lunch |
